ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Global Manufacturing and Quality Learning & Development–JD–Learning Architect (LA) at Eli Lilly and Company - ApplyBlast

Global Manufacturing and Quality Learning & Development–JD–Learning Architect (LA)

Eli Lilly and Company

2 months ago

4.0 on Glassdoor

Alzey, Germany

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Learning Architect (LA) is a platform‑specific learning professional responsible for designing, developing, and maintaining training curricula for Lilly's manufacturing platforms. The role partners with site SMEs, platform leads, and the Center of Excellence to ensure content is current, compliant, and aligned with manufacturing process needs.

Responsibilities

Design and develop platform‑specific training curriculum
Partner with site SMEs and platform leads to ensure content compliance
Support continuous improvement of qualification and training effectiveness

Skills

Qualifications

Bachelor's degree

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.